MedPath

The role of GnRH analogues (medical therapy) in improving fertility in women with early stage endometriosis.

Not Applicable
Completed
Conditions
Health Condition 1: null- infertility due to endometriosis (minimal to mild)
Registration Number
CTRI/2016/08/007162
Lead Sponsor
AIIMS New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

1.Infertile women with minimal or mild endometriosis post laparoscopic surgical treatment.

2.Age less than or equal to 36 yrs.

3.Husband with normal semen parameters

Exclusion Criteria

1.Age > 36 yrs.

2.Moderate or severe endometriosis.

3.Pelvic inflammatory disease including genital Tuberculosis.

4.Poly-Cystic Ovarian Syndrome (PCOS).

5.Endometrial polyp, Sub-mucous myoma.

6.Diminished ovarian reserve as evaluated with FSH >10 IU/ml.

7.Recurrent endometriosis.

8.Male factor infertility.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
clinical pregnancy ratesTimepoint: Confirmation of clinical pregnancy was done by presence of a viable fetus at 6 weeks by ultrasonography
Secondary Outcome Measures
NameTimeMethod
days of stimulationTimepoint: day of administering hCG injection.;dose of gonadotropin injectionTimepoint: calculated using vials containing 150 IU of hMG per vial;Endometrial thicknessTimepoint: greater than or equal to 7mm.;number of folliclesTimepoint: follicle size greater than or equal to 18mm.
© Copyright 2025. All Rights Reserved by MedPath